# T.E.A. Study Three Days Ertapenem Versus Three Days Ampicillin- Sulbactam

> **NCT00630513** · PHASE4 · COMPLETED · sponsor: **University of Bologna** · enrollment: 142 (actual)

## Conditions studied

- Intra-Abdominal Infection

## Interventions

- **DRUG:** Ertapenem
- **DRUG:** Ampicillin-Sulbactam

## Key facts

- **NCT ID:** NCT00630513
- **Lead sponsor:** University of Bologna
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-01
- **Primary completion:** 2010-06
- **Final completion:** 2010-12
- **Target enrollment:** 142 (ACTUAL)
- **Last updated:** 2011-08-18

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00630513

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00630513, "T.E.A. Study Three Days Ertapenem Versus Three Days Ampicillin- Sulbactam". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00630513. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*